Suppr超能文献

雷美替胺诱导的预处理的心脏保护作用需要 PKG 和 Akt 的激活,并且位于 mKCa 通道的上游。

Activation of PKG and Akt Is Required for Cardioprotection by Ramelteon-Induced Preconditioning and Is Located Upstream of mKCa-Channels.

机构信息

Department of Anesthesiology, University Hospital Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany.

Department of Anesthesiology, Amsterdam University Medical Center (AUMC), Location AMC, Meiberdreef 9, 1105 AZ Amsterdam, The Netherlands.

出版信息

Int J Mol Sci. 2020 Apr 8;21(7):2585. doi: 10.3390/ijms21072585.

Abstract

Ramelteon is a Melatonin 1 (MT1)-and Melatonin 2 (MT2)-receptor agonist conferring cardioprotection by pharmacologic preconditioning. While activation of mitochondrial calcium-sensitive potassium (mK)-channels is involved in this protective mechanism, the specific upstream signaling pathway of Ramelteon-induced cardioprotection is unknown. In the present study, we (1) investigated whether Ramelteon-induced cardioprotection involves activation of protein kinase G (PKG) and/or protein kinase B (Akt) and (2) determined the precise sequence of PKG and Akt in the signal transduction pathway of Ramelteon-induced preconditioning. Hearts of male Wistar rats were randomized and placed on a Langendorff system, perfused with Krebs-Henseleit buffer at a constant pressure of 80 mmHg. All hearts were subjected to 33 min of global ischemia and 60 min of reperfusion. Before ischemia, hearts were perfused with Ramelteon (Ram) with or without the PKG or Akt inhibitor KT5823 and MK2206, respectively (KT5823 + Ram, KT5823, MK2206 + Ram, MK2206). To determine the precise signaling sequence, subsequent experiments were conducted with the guanylate cyclase activator BAY60-2770 and the mK-channel activator NS1619. Infarct size was determined by 2,3,5-triphenyltetrazolium chloride (TTC) staining. Ramelteon-induced infarct size reduction was completely blocked by KT5823 ( = 0.0012) and MK2206 ( = 0.0005). MK2206 with Ramelteon combined with BAY60-2770 reduced infarct size significantly ( = 0.0014) indicating that PKG activation takes place after Akt. Ramelteon and KT5823 ( = 0.0063) or MK2206 ( = 0.006) respectively combined with NS1619 also significantly reduced infarct size, indicating that PKG and Akt are located upstream of mK-channels. This study shows for the first time that Ramelteon-induced preconditioning (1) involves activation of PKG and Akt; (2) PKG is located downstream of Akt and (3) both enzymes are located upstream of mK-channels in the signal transduction pathway.

摘要

雷美替胺是褪黑素 1(MT1)和褪黑素 2(MT2)受体激动剂,通过药理预处理发挥心脏保护作用。虽然线粒体钙敏钾(mK)通道的激活参与了这种保护机制,但雷美替胺诱导心脏保护的特定上游信号通路尚不清楚。在本研究中,我们(1)研究了雷美替胺诱导的心脏保护是否涉及蛋白激酶 G(PKG)和/或蛋白激酶 B(Akt)的激活,(2)确定了 PKG 和 Akt 在雷美替胺诱导预处理信号转导通路中的精确顺序。雄性 Wistar 大鼠的心脏被随机分配并放置在 Langendorff 系统上,在 80mmHg 的恒定压力下用 Krebs-Henseleit 缓冲液灌注。所有心脏均经历 33 分钟的整体缺血和 60 分钟的再灌注。在缺血前,心脏用雷美替胺(Ram)灌注,或分别用蛋白激酶 G 或 Akt 抑制剂 KT5823 和 MK2206 灌注(KT5823+Ram、KT5823、MK2206+Ram、MK2206)。为了确定精确的信号序列,随后的实验使用鸟苷酸环化酶激活剂 BAY60-2770 和 mK 通道激活剂 NS1619 进行。梗死面积通过 2,3,5-三苯基四唑氯化物(TTC)染色确定。KT5823(=0.0012)和 MK2206(=0.0005)完全阻断了雷美替胺诱导的梗死面积减少。雷美替胺与 MK2206 联合 BAY60-2770 显著降低梗死面积(=0.0014),表明 PKG 激活发生在 Akt 之后。雷美替胺与 KT5823(=0.0063)或 MK2206(=0.006)分别与 NS1619 联合也显著降低梗死面积,表明 PKG 和 Akt 位于 mK 通道的上游。这项研究首次表明,雷美替胺诱导的预处理(1)涉及 PKG 和 Akt 的激活;(2)PKG 位于 Akt 下游,(3)在信号转导通路中,两种酶都位于 mK 通道的上游。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/7177737/6f71fe1bb1df/ijms-21-02585-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验